Literature DB >> 19633823

[Ectoparasites. Part 1: lice and fleas].

P Nenoff1, W Handrick, C Krüger, J Herrmann, B Schmoranzer, U Paasch.   

Abstract

Ectoparasites and epidermal parasitic skin diseases are a heterogeneous group of infections of the external layer of the skin. The most common forms world-wide are scabies, lice (Pediculosis capitis, corporis, vestimentorum and pubis), tungiasis and the hookworm-associated Larva migrans cutanea. The head louse is the most widespread parasite in children in Germany. The symptoms, apart from pruritus, eczematous skin eruptions and ictus reactions of the skin, are often unspecific and many differential diagnoses must be considered. Treatment of ectoparasites includes manual procedures, such as repeated cleansing and combing out of lice-infected hair and also local antiparasitic treatment with permethrin, pyrethrum extract, allethrin and dimeticon. Lindan which has been used for decades can no longer be used in medications after 2008 after a decision of the EU Commission. Failure of treatment of head lice can be a result of errors in the treatment which favor survival of the eggs, larvae or adults. This can be a result of too short reaction times and too economical use or unequal distribution of medications, excessive dilution due to wet hair or omitting repeated treatment stages. Additionally resistance of head lice to pyrethrum is a known phenomenon and has been reported in several countries.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19633823     DOI: 10.1007/s00105-008-1502-6

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  10 in total

Review 1.  Therapy for head lice based on life cycle, resistance, and safety considerations.

Authors:  Mark Lebwohl; Lily Clark; Jacob Levitt
Journal:  Pediatrics       Date:  2007-05       Impact factor: 7.124

2.  Therapy for head lice.

Authors:  William B Weil
Journal:  Pediatrics       Date:  2007-09       Impact factor: 7.124

Review 3.  [Scabies].

Authors:  C Hafner
Journal:  Hautarzt       Date:  2009-02       Impact factor: 0.751

4.  Accuracy of diagnosis of pediculosis capitis: visual inspection vs wet combing.

Authors:  Claudia Jahnke; Eline Bauer; Ulrich R Hengge; Hermann Feldmeier
Journal:  Arch Dermatol       Date:  2009-03

Review 5.  Epidermal parasitic skin diseases: a neglected category of poverty-associated plagues.

Authors:  Hermann Feldmeier; Jorg Heukelbach
Journal:  Bull World Health Organ       Date:  2009-02       Impact factor: 9.408

6.  Qualitative and quantitative observations on the flea population dynamics of dogs and cats in several areas of Germany.

Authors:  W Beck; K Boch; H Mackensen; B Wiegand; K Pfister
Journal:  Vet Parasitol       Date:  2006-01-25       Impact factor: 2.738

Review 7.  Pediculus humanus capitis: an update.

Authors:  I Nutanson; C J Steen; R A Schwartz; C K Janniger
Journal:  Acta Dermatovenerol Alp Pannonica Adriat       Date:  2008-12

8.  [Pediculosis capita in childhood: epidemiological and socio-medical results from screening of school beginners].

Authors:  C Jahnke; E Bauer; H Feldmeier
Journal:  Gesundheitswesen       Date:  2008-11-27

9.  A highly efficacious pediculicide based on dimeticone: randomized observer blinded comparative trial.

Authors:  Jorg Heukelbach; Daniel Pilger; Fabíola A Oliveira; Adak Khakban; Liana Ariza; Hermann Feldmeier
Journal:  BMC Infect Dis       Date:  2008-09-10       Impact factor: 3.090

10.  Controlling tungiasis in an impoverished community: an intervention study.

Authors:  Daniel Pilger; Stefan Schwalfenberg; Jörg Heukelbach; Lars Witt; Norbert Mencke; Adak Khakban; Hermann Feldmeier
Journal:  PLoS Negl Trop Dis       Date:  2008-10-22
  10 in total
  2 in total

Review 1.  Head Lice.

Authors:  Laura Meister; Falk Ochsendorf
Journal:  Dtsch Arztebl Int       Date:  2016-11-11       Impact factor: 5.594

2.  [Limited toxicity of the pediculicides pyrethrin, pyrethroids, and permethrin].

Authors:  C Sunderkötter; U Kirchhefer
Journal:  Hautarzt       Date:  2010-10       Impact factor: 0.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.